In race to bring vaccine to market, big pharma struggles to protect its intellectual property rights

In race to bring vaccine to market, big pharma struggles to protect its intellectual property rights

Source: 
CNBC
snippet: 

  • The pharmaceutical industry is being careful to not set any dangerous precedent that may weaken their future intellectual property rights, Milena Izmirlieva from IHS Markit said.
  • The World Health Organization said 21 candidate vaccines are in clinical trials at the moment, meaning they are being tested on human volunteers.
  • Three of them are said to be in the third phase of those trials, according to the WHO.